Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
8.56M
-
Number of holders
-
137
-
Total 13F shares, excl. options
-
93.3M
-
Shares change
-
+4.18M
-
Total reported value, excl. options
-
$1.47B
-
Value change
-
+$63.7M
-
Put/Call ratio
-
0.19
-
Number of buys
-
60
-
Number of sells
-
-61
-
Price
-
$15.76
Significant Holders of Atara Biotherapeutics, Inc. - Common Stock (ATRA) as of Q4 2021
153 filings reported holding ATRA - Atara Biotherapeutics, Inc. - Common Stock as of Q4 2021.
Atara Biotherapeutics, Inc. - Common Stock (ATRA) has 137 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 93.3M shares
.
Largest 10 shareholders include BAUPOST GROUP LLC/MA (8.48M shares), MAVERICK CAPITAL LTD (7.86M shares), BlackRock Inc. (7.82M shares), JPMORGAN CHASE & CO (7.42M shares), VANGUARD GROUP INC (7.08M shares), Redmile Group, LLC (6.44M shares), FMR LLC (5.61M shares), Point72 Asset Management, L.P. (4.61M shares), STATE STREET CORP (4.32M shares), and GOLDMAN SACHS GROUP INC (2.56M shares).
This table shows the top 137 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.